Tiziana Life Sciences – Dr. Howard Weiner has received a competitive research grant from the National Institute of Health (NIH) June 4, 2020 – Posted in: Tiziana Life Sciences (TILS)

  Tiziana Life Sciences plc (“Tiziana” or the “Company”) Tiziana Life Sciences announces that its Scientific Advisory Board Chairman Dr. Howard Weiner received NIH grant to investigate Nasal Anti-CD3 for the treatment of Alzheimer’s disease This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.  New York/London, 4 June 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious…

Continue reading